Saratov JOURNAL of Medical and Scientific Research

Growth factors of fibroblasts and vascular en-dothelium in the early stages of knee osteoarthritis

Year: 2018, volume 14 Issue: №3 Pages: 583-586
Heading: Traumatology and Orthopedics Article type: Original article
Authors: Puchinyan D.M., Gladkova E.V., Karyakina E.V., Romakina N.A., Belova S.V.
Organization:
Summary:

Aim: to compare and study the relationship between the maintenance of vascular endothelial growth factor and acidic fibroblast growth factor in individuals with the initial clinical and radiological manifestations of the degeneration of the hyaline cartilage of the knee joints and healthy people. Material and Methods. 27 women with initial symptoms of knee osteoarthritis (main group, average age

Bibliography:
1 Sazonova NV, Chepeleva MV, Volokitina EA, et al. Idiopathic osteoarthritis of the knee joint of the l-ll stage: immunological aspects. Traumatology and orthopedics of Russia 2008; 3 (49): 11-4
2 Kotova OV. Osteoarthritis: issues of diagnosis and treatment. Consilium Medicum 2013; 15 (9): 45-9
3 Matveev RP, Bragina SV. Current problems of knee osteoarthritis study from the position of orthopedist (literature review). Vestnik of Saint Petersburg University. Ser. 112014; (4): 186-95
4 Chertok VM, Chertok AG, Zenkina VG. Endothelium-dependent regulation of angiogenesis. Cytology 2017; 59 (4): 243-58
5 Gavrilenko Tl, Ryzhkov ON, Parkhomenko AN. Vascular endothelial growth factor in the clinic of internal diseases and its pathogenetic value. Ukrainian Cardiology Journal 2011; (4): 87-95
6 Nefedova ON, Davydova SU. The role of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor (HIF) in tumor angiogenesis. Modern problems of science and education 2015; (3). URL: http://www.science-education.ru/ru/ article/view?id=17924 (date of the application: 26.09.2018
7 Potente М, Gerhardt Н, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011; 146 (6): 873-87. 8 Ornitz DM, Marie PJ. Fibroblast growth factor signaling in skeletal development and disease. Genes Dev 2015; 29 (14): 1463-86
9 Teven CM, Farina EM, Rivas J, Reid R. Fibroblast growth factor (FGF) signaling in development and skeletal diseases. Genes Dis 2014; 1 (2): 199-213
10 Ellman MB, Yan D.Ahmadinia K, Chen D, An HS, Im HJ. Fibroblast growth factor control of cartilage homeostasis. J Cell Biochem 2013; 114 (4): 735-42
11 Nagai H, Aoki MJ. Inhibition of growth plate angiogenesis and endochondral ossification with diminished expression of MMP-13 in hypertrophic chondrocytes in FGF-2-treated rats. Bone Miner Metab 2002; 20 (3): 142-47
12 Badokin VV. Osteoarthritis of the knee. Medical Council 2010; (9-10): 98-103
13 Chichasova NV. Clinical rationale for the use of various forms of the drug teraflex with osteoarthritis. Modern Rheumatology 2010; (4): 59-64
14 Sagalovsky S. Physiological role of growth factors and bone morphogenetic proteins in osteogenesis and bone fracture healing: a review. Almanac of Clinical Medicine 2015; (38): 113-126
15 Teven CM, Farina EM, Rivas J, Reid RR. Fibroblast growth factor (FGF) signaling in development and skeletal diseases. Genes Dis 2014; 1 (2): 199-213
16 Li R, Wang B,. He CQ, Yang YQ, Guo H, Chen Y, Du TH. Upregulation of fibroblast growth factor 1 in the synovial membranes of patients with late stage osteoarthritis. Genetics and Molecular Research 2015; 14(3): 11191-9

AttachmentSize
2018_3-1_583-586.pdf258.28 KB

No votes yet